Allocations
Perwyn, a family-backed private equity and growth capital investor, has led a USD30 million Series C funding round in online personal shopping service Lookiero.
Founded in 2015 by Oier Urrutia, Lookiero combines the expertise of personal shoppers and a deep understanding of its customers with in-house recommendation algorithms to provide a fully personalised style experience to customers. By employing a customer’s style profile, Lookiero delivers a carefully curated selection of five pieces of clothing and accessories to fit a customer’s individual size, style, and preferences. Customers then decide which items to keep or return (at no additional cost), enabling Lookiero’s
Pemberton, a European private debt manager transforming traditional credit markets, backed by one of Europe’s largest insurers, Legal & General Group, has arranged and underwritten a EUR265 million bond to support circular economy and recycling leader ReLife Group’s growth via acquisitions.
ReLife is a leading private Italian circular economy player focused on recycling of urban and industrial dry waste. Xenon Private Equity is its largest shareholder. The company’s 18 production sites are located in Liguria, Piedmont, Lombardy, Veneto and Tuscany, with activities organised into four divisions: recycling, paper mill, paper packaging and plastic packaging.
The financing is aimed at
OTB Ventures, a venture capital firm investing in early-stage technology businesses with R&D in Central and Eastern Europe (CEE) and global potential, has launched the new OTB Growth Fund I.
The fund, totalling USD60 million, provides OTB Ventures with the capabilities to support its successful portfolio companies with additional follow-on investments as they scale-up to pursue and accelerate international growth opportunities. The fund is backed by the ESCALAR programme of the European Commission and the European Investment Fund (EIF), a new investment approach supporting venture capital and growth financing for promising European companies.
Today’s news follows from the 2020
ISA Pharmaceuticals, a clinical-stage immunotherapy company, has closed a EUR26 million funding round with participation from new investors including Invest-NL and existing investors including Regeneron.
The proceeds of this round will be used to advance the lead product ISA101b towards first marketing authorisation as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic Long Peptide (SLP) platform technology.
Gerben Moolhuizen, CEO of ISA Pharmaceuticals, says: “We are very happy with the continued support of our existing partners and shareholders. Invest-NL’s support underlines the innovation at ISA Pharma and potential impact of our SLP immunotherapies for
Fondsdepot Bank, a German liability umbrella provider, has partnered with Moonfare, a digital investment platform for top-tier private markets funds.
Fondsdepot Bank will provide Moonfare with regulatory support to its continued growth across Europe. As part of the agreement, the fund platform has extended its liability umbrella license to operate in select European countries where Moonfare operates.
“At Moonfare, adherence to financial regulation is a topic where we absolutely refuse to compromise,” says Moonfare Managing Director and COO Lorenz Jüngling. “We may be a relatively young company, but in these areas we hold ourselves to the same standards as the
Apaczka, a provider of logistics solutions for e-commerce in Poland, backed by the Central European private equity investor Abris Capital Partners, has acquired Sendit, a parcel delivery platform for individual customers in Poland.
Apaczka is the largest online logistics platform in Poland, operating as an end-to-end multi-carrier shipment intermediary dedicated to e-commerce shops, SMEs and SOHO (small office/home office) clients, cooperating with leading players in the Polish courier delivery market such us UPS, DPD, DHL, FedEx and InPost. Abris acquired Apaczka in November 2020, with a plan to capitalize on the ongoing growth of e-commerce globally, at the same time
Kempen Capital Management (Kempen) is to launch the Kempen European Private Equity Fund II, which will focus on small and medium-sized private enterprises in Northern and Western Europe with an enterprise value of up to EUR100 million.
The Kempen European Private Equity Fund II is a closed-end investment fund with a term of approximately 10 years. This is Kempen’s second private equity fund after having successfully launched the first Kempen European Private Equity Fund early in 2019. It resembles its predecessor in that it is a hybrid investment fund that combines indirect investments in private equity funds and co-investments. Approximately
Dutch healthcare group Intergrin has obtained a cEUR50 million unitranche loan, provided by Kartesia, to refinance existing debt and to further support the growth of different healthcare and wellbeing initiatives of the company.
Owned by IIC Group and headquartered in Geleen, Intergrin operates clinics focused on specialist mental healthcare through two providers, Het Rughuis and PHI. Het Rughuis provides psychosomatic treatment to individuals with a spinal-related pain disorder through a combination of expert cognitive behavioural therapy, lifestyle-as-a-medicine therapy, vitality and physical therapy. PHI offers specialised psychosomatic mental healthcare for those suffering from anxiety, depression, somatoform disorder and serious unexplained physical
Golub Capital has reported record originations in the second quarter of 2021, signing up over USD9 billion in retained and syndicated commitments and completing over 95 new and add-on transactions.
Originations in the quarter were 30 per cent higher than the fourth quarter of 2020, the Firm’s previous record quarter.
“Golub Capital is firing on all cylinders in this post-Covid period, reflecting the power and the resilience of our award-winning, market-leading sponsor finance business,” says David Golub, President of Golub Capital.
Second quarter financings ranged in size from USD10 million to in excess of USD2 billion and included
Forward Partners, a London-based venture capital firm specialising in supporting high growth, early-stage technology businesses, has announced plans for a proposed admission to trading on AIM and associated placing of 34,749,490 new ordinary shares of 1 penny each at a price of 100 pence per share.
The Company has also made a separate offer via the PrimaryBid platform to retail investors and applications for a total of 1,750,510 new ordinary shares of 1 penny each at the Placing Price have been received.
The listing was oversubscribed – the issue of the Placing Shares and the Offer Shares will raise gross proceeds
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
